Emami share news and announcements
NSE: EMAMILTDBSE: 531162Personal ProductsSmall Cap
Last close ₹373.15down ₹4.15 (1.10%)BSE ₹373.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹377.30.
52-week range of traded prices to 23 Oct 2026
₹361.15Low, 1 Sep 2026₹556.15High, 28 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹16,016 Cr349th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 4 Aug 2026
- 21.4
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 13 Jul 2026
- 5.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.68%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 4 Aug 2026
- 26.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 4 Aug 2026
- 26.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 13 Jul 2026
- 0.04
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 8,15,20952.5% delivered
Emami share news and announcements
1,137 announcements, routine notices left out, newest first. Page 22 of 23.
Jun 2010
3 Jun · Demise of Director
Shri S N Jalan is no more member of the Board of the Company due to his sudden demise on May 24, 20103 Jun · Updates
Shri Amit Deb an Independent Director has been appointed as member of Audit Committee of the Company with effect from May 25, 2010.
May 2010
28 May · Share Split
Board of Directors at their meeting held on May 28, 2010 has approved sub-division of face value of Equity Share of Rs.2/- each to Re.1/- each subject to approval of members of the Company.28 May · Dividend
Board of Directors at its meeting held on May 28, 2010 has proposed Dividend of Rs. 6.00 per share, i.e. 300% on the share capital of the Company.14 May · Board meeting
Inter-alia, to approve audited annual accounts and to consider and if thought fit, to recommend a dividend for the year ended March 31, 2010.
Apr 2010
7 Apr · Results
We shall be publishing Audited Annual Accounts for the financial year ended March 31, 2010 within the stipulated period instead of publishing unaudited financial results for the fourth quarter ended March 31, 2010.5 Apr · News Verification
News Verification : The media had reports on April 03, 2010, that Emami Limited may acquire shares of Amrutanjan Health Care Limited. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Emami Limited has vide its letter inter-alia stated,"Our group is interested in acquisition opportunities for Pharma and FMCG business in India and abroad for in-organic growth of the company. In the stated media report, our chairman has only expressed his desire to acquire any FMCG or Pharma business/company including Amrutanjan within the financial and operational resources of the company. We, however, do not hold any shares in that company."
Feb 2010
2 Feb · Management
At the meeting of Board of Directors of the Company held on 30th January 2010, Shri S B Ganguly, Shri Amit Kiran Deb, Shri Y P Trivedi and Mrs Priti Sureka were appointed as Additional Directors of the Company. Shri S B Ganguly, Shri Amit Kiran Deb and Shri Y P Trivedi are representing as Independent Directors on the Board of the Company and Mrs. Priti Sureka as Whole time Director. Further, Shri K K Khemka an Independent Director on the Board of the Company has resigned with effect From 30th January 2010
Jan 2010
20 Jan · Board meeting
Meeting on 30 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”15 Jan · Allotment of Equity Shares
In terms of Scheme of Arrangement as approved by Hon'ble Calcutta High Court, the Company has allotted 35,10,696 Equity Shares of Rs 2 /- each fully paid up on 14th January 2010 to shareholders of the The Zandu Pharmaceuticals Works Ltd (Zandu) whose names appear in the Register of Members of Zandu at the end of working hours on 23rd December 20098 Jan · Meeting
Proceedings of the Annual General Meeting held on December 31, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2009
9 Dec · Meeting
Board of Directors of the Company at its meeting held on December 03, 2009 has decided to convene the Annual General Meeting of the Company on December 31, 2009 and has also decided to close the close the register of members and share transfer books of the Company from December 24, 2009 to December 31, 2009 to determine the entitlement to: 1) Dividend as recommended by the Board of Directors and if approved by the members at the ensuing Annual General Meeting; 2) Equity shares of Emami Infrastructure Ltd. in terms of the Scheme of Arrangement of demerger of realty undertaking of the Company and transfer into Emami Infrastructure Ltd. Further, the company has informed the Exchange that the scheme proposes Emami Infrastructure Ltd (EIL) to issue 1(one) equity share of Rs 2(two) each for every 3(three) equity shares of Rs 2(two) each held in Emami for the demerger of Realty business of Emami into EIL. Further, the Company has submitted to the Exchange the Short Note on the Scheme of Arrangement alongwith the details as required under clause 20 of the Listing Agreement. The copies of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Dec · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended September 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Dec · Dividend
Board of Directors of the Company held on December 03, 2009 has recommended a dividend of Rs.4.50 per share (i.e.225%) subject to the approval of members. The dividend, if approved, will be paid to the members of the Company and the shareholders of The Zandu Pharmaceutical Works Ltd whom equity shares of Emami Ltd will be allotted on demerger of Zandu FMCG undertaking in terms of clause 6.5 of Part III of the Scheme of Arrangement under Sections 391 to 394 of the Companies' Act, 1956.3 Dec · Business
Hon'ble Calcutta High Court has approved the Scheme of Arrangement under section 391 to 394 of the Companies Act 1956, between Emami Ltd, The Zandu Pharmaceuticals Workers Ltd and Emami Infrastructure Ltd on 17th November 2009 and certified copy of the said Order has been filed with the Registrar of Companies, West Bengal on 2nd December 2009 to make the scheme effective.
Nov 2009
24 Nov · Board meeting
Inter-alia, to approve audited annual accounts and to consider and if thought fit, to recommend a dividend for the year ended March 31, 2009.
Oct 2009
23 Oct · Meeting
Company has received an approval from Ministry of Corporate Affairs, Office of Registrar of Companies, West Bengal for extension of time for holding Annual General Meeting of the Company under section 166(1) of the Companies Act, 1956 for the financial year ended March 31, 2009.15 Oct · Board meeting
Inter-alia, to consider, approve and take on record the Unaudited Financial Results of the Company for the Second Quarter ended September 30, 2009.6 Oct · Disclosure
Raj Kumar Goenka, being the authorized representative of the Promoters and Persons acting in concert in respect of Equity Shares of Emami Limited, has submitted to the Exchange the Disclosure under Regulation 7(1A) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Oct · Disclosure
Disclosure of acquisition of shares in terms of Regulation 7(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997, in reference to the disclosure received by the Company on September 24, 2009 from Shri Raj Kumar Goneka on behalf of the Promoters and / or Persons acting in concert under Regulation 7(1A) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2009
17 Sep · Business
At the meeting of the Equity Shareholders of the Company held on September 11, 2009 convened on the direction of the High Court of Calcutta, the shareholders have approved the Scheme of Arrangement in terms of Section 391 to 394 of the Companies Act, 1956 between Emami Ltd, The Zandu Pharmaceutical Works Ltd and Emami Infrastructure Ltd.3 Sep · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
18 Jul · Board meeting
Inter-alia, to consider, approve and take on record the Unaudited Financial Results of the Company for the First Quarter ended June 30, 2009.2 Jul · Business
Qualified Institutional Placement (QIP) of Emami Limited of Equity Shares of Rs.2/- each as determined by the Book Building Process under "Chapter XIIIA - Guidelines for Qualified Institutional Placement" of the SEBI (Disclosure and Investor Protection) Guidelines, 2000, as follows: "The duly authorised committee of the Board of Directors viz. Share Transfer and Shareholders / Investors Grievance Committee, at its meeting held on July 2, 2009 has decided to close the issue and has approved the issuance of 1,00,00,000 (One Crore) Equity Shares of Rs.2/- each for cash at a price Rs.310/- per Equity Share (including a premium of Rs. 308/- per Equity Share) aggregating to Rs.310/- Crore (Rupees Three Hundred and Ten Crore only)".
Jun 2009
19 Jun · Board meeting
Board of Directors of the Company and The Zandu Pharmaceutical Works Limited ("Zandu") today approved:- (a) the demerger of the Realty Undertaking of Emami Limited into a separate company viz. Slick Properties Private Limited to be renamed as 'Emami Infrastructure Limited'. (b) the demerger of the FMCG Undertaking of Zandu into Emami Limited. (c) Realty Undertaking of Emami Limited includes its investment in wholly owned subsidiary Emami Realty Limited and its investment in equity shares of Zandu representing the carrying value of investment in the remaining business after the demerger of the Zandu's FMCG Undertaking i.e. Zandu's non-core undertaking. The Zandu's non-core undertaking to be renamed as "Zandu Realty Limited", each of the demergers shall be conditional upon the other". The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Jun · Board meeting
To inter-alia, consider and approve the Scheme of Arrangement for restructuring and reorganizing of FMCG and Realty business being carried on by Emami Ltd and its subsidiary Companies i.e. the Zandu Pharmaceutical Works Ltd and Emami Realty Ltd.1 Jun · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter and year ended March 31, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2009
21 Apr · Board meeting
Meeting on 29 Apr 2009: “Unaudited Financial Results for the qtr ended March 31, 2009”
Mar 2009
30 Mar · Board meeting
Board of Directors of the Company has, in its meeting held on March 30, 2009, discussed various options for restructuring and reorganizing FMCG and Realty business carried on by Emami Ltd and subsidiaries i.e. Zandu Pharmaceutical Works Ltd and Emami Realty Ltd and authorized and empowered the Committee of the Board of Directors of the Company constituted for this purpose, to do the followings: (1) To examine and evaluate restructuring and reorganizing of FMCG and realty business being carried on by these companies through merger, demerger or any other arrangement. (2) To appoint advocates, legal advisors, valuers, merchant bankers and any other experts for taking their views and opinions in this respect; (3) To frame appropriate scheme and recommend to the Board of Directors of the Company; (4) To do all such acts and deeds which are necessary in this respect.26 Mar · Board meeting
Inter-alia, to discuss and consider various options of restructuring and reorganizing the business of the Company and its Subsidiary Companies viz. The Zandu Pharmaceutical Works Ltd and Emami Realty Ltd.13 Mar · Limited Review Report
Auditor's have conducted the limited review of the Unaudited financial results for the quarter ended December 31, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Mar · Disclosure
Disclosure of acquisition of shares in terms of Regulation 7(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. A copy of the disclosure shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Mar · Disclosure
Disclosure under Regulation 7(1A) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. A copy of the disclosure shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Mar · Notice
Notice under Section 302 of the Companies Act, 1956 for terms of reappointment of the Executive Chairman Shri R.S. Agarwal. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2009
11 Feb · Disclosure
Disclosure under Regulation 8A(4) of SEBI (Substantial Acquisition of Shares and Takeovers)(Amendment) Regulations 2009. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
12 Jan · Board meeting
Company had informed the Exchange that the Meeting of Board of Directors of the Company is scheduled to be held on January 27, 2009, inter-alia to consider, approve and take on record unaudited Financial Results of the Company for the third quarter ended December 31, 2008. The Company has now informed the Exchange that the aforesaid meeting has been re-scheduled on January 28, 2009 instead of January 27, 2009.5 Jan · Board meeting
Meeting on 27 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Nov 2008
18 Nov · Limited Review Report
Auditor's have conducted the limited review of the Unaudited financial results for the quarter ended September 30, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Nov · Results
Result of the voting conducted through Postal Ballot under Section 192A of the Companies Act, 1956 on the resolutions set out in Notice dated October 03, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Nov · Subsidiary
Consequent upon completion of the Open Offer to acquire 1,61,280 equity shares i.e. 20% of the votings rights of the Zandu Pharmaceutical Works Limited (Zandu) by Emami Limited, the aggregate shareholding of Emami Limited in Zandu has become 66.44% of the total paid up equity share capital of Zandu on November 03, 2008. By virtue of the aforesaid shareholding, The Zandu Pharmaceutical Works Limited has become Subsidiary Company of Emami Limited.
Oct 2008
23 Oct · Divestment
At the meeting of Board of Directors of the Company held on October 21, 2008, the Board has inter-alia decided to divest its entire stake/ shares held in its wholly subsidiary Company "Emami Realty Limited".16 Oct · Business
Vide its letter dated October 15, 2008, that: "Pursuant to the settlement efforts initiated by the Hon'ble Company Law Board vide its order dated 22nd September, 2008, the Company has acquired, in terms of a Share Purchase Agreement entered with the existing promoters of The Zandu Pharmaceuticals Works Limited (Zandu) and their relatives, friends and associates, 146643 equity shares comprising of 18.18% of the total paid up capital of Zandu at a price of Rs 15,000/- (Rupees Fifteen Thousand only) per share and also a non compete fee of Rs 1500/- (Rupees One Thousand five hundred only) per equity share. Please be further informed that by separate transactions, the company has today further acquired 37417 Equity shares of Zandu, as per details given herein under: i) No of Shares - 4103; % of paid up Equity Capital - 0.51%; Price per share - 14440.90. ii) No of Shares - 33314; % of paid up Equity Capital - 4.13%; Price per share - 14356.65".15 Oct · Board meeting
Meeting on 21 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”6 Oct · Corrigendum
Acquirer along with PACs have revised the Offer Price in respect of the Public Offer made by Emami Limited for acquisition of Equity Shares of The Zandu Pharmaceutical Works Limited from Rs. 15,000/- per equity share to Rs. 16,500/- per equity share. Further, Emami Limited has submitted to the Exchange a copy of Corrigendum published on October 03, 2008, with reference to Open Offer to acquire up to 1,61,280 equity shares representing up to 20% of the voting rights of The Zandu Pharmaceutical Works Limited (ZPWL) (Target Company) by Emami Limited (the Acquirer) and Bhanu Vyapaar Private Limited (BVPL), Suraj Viniyog Private Limited (SVPL), Diwakar Viniyog Private Limited (DVPL) and Suntrack Commerce Private Limited (SCPL) collectively referred to as the 'Person Acting in Concert/ PAC's at a Offer Price of Rs. 16,500/- (Rupees Sixteen Thousand Five Hundred only) per equity share (Being the Offer Price revised from Rs. 15,000/- per equity Share to Rs. 16,500/- per equity share). A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Oct · Board meeting
Board of Directors of the Company at its meeting held on October 03, 2008 decided, inter alia, the following business:1. Seeking Approval of the shareholders under section 372A of the Companies Act 1956 through postal ballot for making further investment up to a sum of Rs. 430 Crores (Rupees Four Hundred Thirty Crores only) in acquisition of shares of The Zandu Pharmaceuticals Works Ltd. which is in addition to existing limit / approval available with the Company. 2) Revising the limit of borrowings under section 293(1)(d) of the Companies Act, 1956 from Rs 500 Crores to Rs.1500 Crores subject to the approval of shareholders through Postal Ballot. 3) Alteration in clause 21 of other Object Clause of the Memorandum of Association of the Company by substituting the said clause with the new clause relating to power generation and distribution subject to the approval of shareholders through Postal Ballot. 4) Commencement of new business activities Coal Mining and Power Generation & Distribution subject to the approval of shareholders under section 149(2A) of the Companies Act,1956 through postal ballot.3 Oct · Updates
In terms of Regulation 26 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation 1997, the Company alongwith PACs have revised the offer price in respect of the Public Offer made by it for acquisition of Equity Shares of The Zandu Pharmaceutical Works Limited from Rs. 15,000/- per equity share to Rs. 16,500/- per equity share. As required under the aforesaid regulation 26 the Company is making suitable arrangements for issuing corrigendum to PA in all the newspapers in which the original public announcement were made
Sep 2008
22 Sep · Corrigendum
Corrigendum to Public Announcement with reference to Open Offer to acquire up to 1,61,280 equity shares representing up to 20% of the voting rights of the Zandu Pharmaceutical Works Limited (ZPWL) (Target Company) by Emami Limited (Acquirer) and Bhanu Vyapaar Private Limited (BVPL), Suraj Viniyog Private Limited (SVPL), Diwakar Viniyog Private Limited (DVPL) and Suntrack Commerce Private Limited (SCPL) collectively referred to as the 'Person Acting in Concert/ PAC's at a Offer Price of Rs. 15,000/- (Rupees Fifteen Thousand only) per equity Share (Being the Offer Price revised from Rs.7,315/- per equity share to Rs. 15000/- per equity share). A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Sep · Meeting
Proceedings of the Annual General Meeting of the members of the Company held on August 25, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Sep · Updates
In terms of Regulation 26 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation 1997, the Company has revised the offer price in respect of the Public Offer made by it for acquisition of Equity Shares of The Zandu Pharmaceutical Works Limited from Rs 7315/- to Rs 15,000/- per share. As required under the aforesaid regulation 26 the Company is making suitable arrangements for issuing corrigendum to Public Announcement in all the newspapers in which the original public announcement were made